Humacyte Share Price

Humacyte Share Price

NASDAQ: HUMAW | Healthcare
$0.00
+0.00 (0.00%)
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • About
  • Price history
  • FAQs

Humacyte Stock Performance

Open
N/A
Prev. Close
N/A
Circuit Range
N/A
Day Range
N/A
Year Range
N/A
Volume
N/A
Average Traded
N/A

Humacyte Share Price Chart

$0.00$0.00
L
Show Current Price
H

Humacyte Stock Fundamentals & Key Indicators

Market Cap
N/A
PE Ratio (TTM)
N/A
Dividend Yield
N/A
EPS (TTM)
N/A
Revenue (TTM)
$2.04B
Return On Equity (TTM)
-309.44%
Profit Margin
-2001.47%
Debt to Equity
2.12
Quarterly Earnings Growth YoY
-110.17%

Humacyte Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.75$0.47$0.50$0.41
Net Profit-$17.51-$24.80-$17.62-$36.80
Net Profit Margin-2334.67%-5276.60%-3524.00%-8975.61%
Income ChangeN/A-41.63%28.95%-108.85%

Humacyte Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$1.57$0.00$0.00$2.04
Net Profit-$11.97-$110.78-$148.70-$40.83
Net Profit Margin-762.42%N/AN/A-2001.47%
Income ChangeN/A-825.48%-34.23%72.54%

Humacyte Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets48.5790.0144.9550.09
Current Assets67.847.8683.28154.21
Total Assets116.37137.87128.22204.3
Non Current Liabilities94.89170.5996.2367.79
Current Liabilities18.3719.9518.4419.58
Total Liabilities113.26190.54114.6887.37
Shareholders' Equity3.11-52.6713.55116.93

Humacyte Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating-105.04-98.12-83.334.64
Investing-0.88-1.57-0.174.85
Financing61.49114.1814.53-77.21

About Humacyte

Humacyte Inc is developing a commercial-stage biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.

Humacyte Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %

Humacyte Share Price FAQs